UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Liver stiffness in the hepatitis B virus carrier： A non-invasive marker of liver disease influenced by the pattern of transaminases

World journal of gastroenterology : WJG, 2008-10, Vol.14 (40), p.6154-6162

2008

Link zum Volltext

Verfügbarkeit prüfen

Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease

Diabetes/metabolism research and reviews, 2024-02, Vol.40 (2), p.e3736-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

PloS one, 2015-06, Vol.10 (6), p.e0130209-e0130209

2015

Link zum Volltext

Verfügbarkeit prüfen

A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection

PloS one, 2014-10, Vol.9 (10), p.e110782-e110782

2014

Link zum Volltext

Verfügbarkeit prüfen

Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort

Hepatology (Baltimore, Md.), 2017-12, Vol.66 (6), p.1814-1825

2017

Link zum Volltext

Verfügbarkeit prüfen

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

PloS one, 2017-10, Vol.12 (10), p.e0185728-e0185728

2017

Link zum Volltext

Verfügbarkeit prüfen

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years

Journal of hepatology, 2012-06, Vol.56 (6), p.1254-1258

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

Journal of hepatology, 2002-02, Vol.36 (2), p.263-270

2002

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B surface antigen seroclearance is uncommon but durable in the long run

Hepatology (Baltimore, Md.), 2024-06, Vol.79 (6), p.1258-1260

2024

Link zum Volltext

Verfügbarkeit prüfen

A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers

Transplantation, 2008-12, Vol.86 (12), p.1666

2008

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers

Gastroenterology (New York, N.Y. 1943), 2010-08, Vol.139 (2), p.483-490

2010

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

Hepatology (Baltimore, Md.), 2009-04, Vol.49 (4), p.1141-1150

2009

Link zum Volltext

Verfügbarkeit prüfen

Highly dynamic changes of regional HBV epidemiology over two decades

Digestive and liver disease, 2023-04, Vol.55 (4), p.519-526

2023

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

Digestive and liver disease, 2021-05, Vol.53 (5), p.612-619

2021

Link zum Volltext

Verfügbarkeit prüfen

TREATMENT OF HEPATITIS C VIRUS INFECTION IN ITALY: A CONSENSUS REPORT FROM AN EXPERT PANEL

Digestive and liver disease, 2017-07, Vol.49 (7), p.731-741

2017

Link zum Volltext

Verfügbarkeit prüfen

Optimization of in vitro HBV replication and HBsAg production in HuH7 cell line

Journal of virological methods, 2013-04, Vol.189 (1), p.110-117

2013

Link zum Volltext

Verfügbarkeit prüfen

Acute and Severe Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy in Patients with Graves' Ophthalmopathy

Thyroid (New York, N.Y.), 2004-05, Vol.14 (5), p.43-406

2004

Link zum Volltext

Verfügbarkeit prüfen

Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C

Liver international, 2007-06, Vol.27 (5), p.612-619

2007

Link zum Volltext

Verfügbarkeit prüfen

Long term response to therapy of chronic anti-HBe–positive Hepatitis B is poor independent of type and schedule of interferon

The American journal of gastroenterology, 1999-05, Vol.94 (5), p.1366-1372

1999

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B

Gastroenterology (New York, N.Y. 1943), 1993-09, Vol.105 (3), p.845-850

1993

Link zum Volltext

Verfügbarkeit prüfen

Wild-Type and e Antigen-Minus Hepatitis B Viruses and Course of Chronic Hepatitis

Proceedings of the National Academy of Sciences - PNAS, 1991-05, Vol.88 (10), p.4186-4190

1991

Link zum Volltext

Verfügbarkeit prüfen

Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis

Journal of medical virology, 1997-04, Vol.51 (4), p.313-318

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektioneBooks on EBSCOhost

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Liver stiffness in the hepatitis B virus carrier： A non-invasive marker of liver disease influenced by the pattern of transaminases

Simple proxies of insulin resistance identify obese metabolic dysfunction‐associated fatty liver disease subjects with advanced liver disease

Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease

A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection

Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)

HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany

Hepatitis B surface antigen seroclearance is uncommon but durable in the long run

A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers

Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

Highly dynamic changes of regional HBV epidemiology over two decades

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

TREATMENT OF HEPATITIS C VIRUS INFECTION IN ITALY: A CONSENSUS REPORT FROM AN EXPERT PANEL

Optimization of in vitro HBV replication and HBsAg production in HuH7 cell line

Acute and Severe Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy in Patients with Graves' Ophthalmopathy

Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C

Long term response to therapy of chronic anti-HBe–positive Hepatitis B is poor independent of type and schedule of interferon

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B

Wild-Type and e Antigen-Minus Hepatitis B Viruses and Course of Chronic Hepatitis

Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis

Aktive Filter

Suchergebnisse filtern